DNA and RNA sample preparation provides accessibility to nucleic acids in natural form, removing unwanted contaminants. The process of DNA and RNA sample preparation has become highly refined. Multi-national companies are actively focusing on the development of faster and accurate products, which include workstations, kits, and reagents & consumables. Persistence Market Research (PMR), in its report titled, “DNA and RNA Sample Preparation Market: Global Industry Analysis and Forecast, 2017-2025” has provided a detailed analysis on the global DNA and RNA sample preparation market.
Kits Product-type Segment Expected to Hold Largest Market Share
PMR estimates that kits for DNA and RNA sample preparation would account for around 60% market share in 2017. However, this product type segment is expected to witness a slight decline in its market share by 2025-end. Although kits will experience a decline in their market share, they are estimated to hold the largest market share in the global DNA and RNA sample preparation market during the forecast period. Workstations are expected to exhibit the fastest growth at 5.8% CAGR through 2025.
Request Sample Report@ https://www.persistencemarketresearch.com/samples/3211
Soaring Demand for Modern Extraction Techniques Estimated to Drive Market Growth
The global DNA and RNA sample preparation market is projected to register a steady growth at 5.5% CAGR during the forecast period. The US$ 1,293.6 Mn market is estimated to reach US$ 2,090.2 Mn through 2025. Investment in basic research, particularly by academic & research institutes, since past several years have led to solid understanding of fundamental pathways. Through this, various proteins implicated in disease development are either up-regulated or down-regulated. In addition, growing requests by researchers for complex products is an evidence of improvement in understanding basic pathways and discovering new pathways. These factors lead to greater knowledge of cellular pathways, which in turn are estimated to fuel the demand for DNA and RNA sample preparation in the near future.
Technological advancements in nucleic acid preparation processes have driven a greater demand for high quality kits, reagents, and associated products. Technological advancements in the methods of DNA and RNA sample preparation, global agreement between leading research institutes for boosting research activities in molecular biology field, soaring demand for modern extraction techniques, and technological advancements in analytical instruments are some major factors driving the market growth. However, increasing inclination of preferences for premium products, owing to their higher quality as compared to standard reagents and products, is expected to restrain the growth of the global DNA and RNA sample preparation market.
Hospitals to be Second-most Lucrative End User by 2025-End
Academic and research institutes are expected to be the most lucrative end user in the global DNA and RNA sample preparation market through 2025. This segment is expected to exhibit 5.9% CAGR during the forecast period. Hospitals are expected to be the second most lucrative end user segment in the overall market. Based on applications, research applications are expected to remain dominant in the global DNA and RNA sample preparation market during the forecast period. Clinical testing, following research applications, are expected to exhibit 5.4% CAGR through 2025.
Request Report TOC@ https://www.persistencemarketresearch.com/methodology/3211
Asia Pacific to Register a CAGR similar to North America
North America is estimated to be the largest region for DNA and RNA sample preparation market, and is expected to account for more than 40% market share by 2025 end. Although Europe is expected to be the second-most lucrative region for the market, Asia Pacific is estimated to exhibit a comparatively faster growth during the forecast period. Key players in the global DNA and RNA sample preparation market include Agilent Technologies, Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Illumina, Inc., PerkinElmer, Inc., QIAGEN, Sigma-Aldrich Corporation, Tecan Group AG, and Thermo Fischer Scientific, Inc.